Liquidia Corp. (LQDA)
39.47
-1.93
(-4.66%)
USD |
NASDAQ |
Apr 17, 16:00
39.43
-0.04
(-0.10%)
After-Hours: 20:00
Liquidia SG&A Expense (Quarterly) : 48.24M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 82.79M |
| ADMA Biologics, Inc. | 24.64M |
| Lexicon Pharmaceuticals, Inc. | 8.757M |
| aTyr Pharma, Inc. | 3.905M |
| Kura Oncology, Inc. | 39.14M |